← Evidence map

ArticleAnnals of medicine and surgery (2012)2025

FDA approves Resmetirom: groundbreaking treatment for NASH liver scarring in moderate to advanced fibrosis.

Aiman Waheed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40213239